5.8173
price up icon1.73%   0.0273
 
loading
Kodiak Sciences Inc stock is traded at $5.8173, with a volume of 20,601. It is up +1.73% in the last 24 hours and up +60.49% over the past month. Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
See More
Previous Close:
$5.79
Open:
$5.79
24h Volume:
20,601
Relative Volume:
0.08
Market Cap:
$302.53M
Revenue:
-
Net Income/Loss:
$-197.68M
P/E Ratio:
-1.0206
EPS:
-5.7
Net Cash Flow:
$-158.88M
1W Performance:
+11.13%
1M Performance:
+60.49%
6M Performance:
+83.49%
1Y Performance:
+161.78%
1-Day Range:
Value
$5.79
$5.93
1-Week Range:
Value
$5.08
$6.00
52-Week Range:
Value
$2.185
$7.77

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
Name
Kodiak Sciences Inc
Name
Phone
650-281-0850
Name
Address
1200 PAGE MILL RD, PALO ALTO, CA
Name
Employee
108
Name
Twitter
@kodiaksciences
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
KOD's Discussions on Twitter

Compare KOD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
KOD 5.8869 302.53M 0 -197.68M -158.88M -5.70
VRTX 447.65 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.99 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.27 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.68 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.49 24.49B 3.30B -501.07M 1.03B 11.54

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-05-24 Initiated H.C. Wainwright Neutral
Dec-11-23 Resumed Goldman Sell
Nov-17-23 Upgrade CapitalOne Equal Weight → Overweight
Jul-27-23 Downgrade UBS Buy → Neutral
Jul-25-23 Downgrade Chardan Capital Markets Buy → Neutral
Jul-25-23 Downgrade JP Morgan Neutral → Underweight
Jul-24-23 Downgrade CapitalOne Overweight → Equal Weight
Jul-24-23 Downgrade Jefferies Buy → Hold
Nov-15-22 Initiated CapitalOne Overweight
Aug-02-22 Downgrade Citigroup Neutral → Sell
Feb-24-22 Downgrade JP Morgan Overweight → Neutral
Feb-11-22 Initiated Goldman Buy
Feb-02-22 Upgrade JP Morgan Neutral → Overweight
May-11-21 Upgrade ROTH Capital Neutral → Buy
Mar-12-21 Initiated Evercore ISI Outperform
Mar-01-21 Downgrade Barclays Equal Weight → Underweight
Feb-17-21 Downgrade ROTH Capital Buy → Neutral
Jan-25-21 Downgrade BMO Capital Markets Outperform → Market Perform
Dec-17-20 Initiated Berenberg Buy
Dec-16-20 Initiated UBS Buy
Dec-11-20 Initiated Citigroup Neutral
Nov-30-20 Downgrade JP Morgan Overweight → Neutral
Nov-16-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-13-20 Downgrade Goldman Buy → Neutral
Mar-31-20 Initiated BMO Capital Markets Outperform
Mar-03-20 Initiated Goldman Buy
Feb-18-20 Downgrade Barclays Overweight → Equal Weight
Feb-06-20 Initiated SunTrust Buy
Jan-08-20 Initiated ROTH Capital Buy
Jan-03-20 Initiated Jefferies Buy
Dec-24-19 Initiated JP Morgan Overweight
Oct-15-19 Reiterated Chardan Capital Markets Buy
Feb-20-19 Initiated Chardan Capital Markets Buy
Oct-29-18 Initiated Barclays Overweight
Oct-29-18 Initiated BofA/Merrill Buy
Oct-29-18 Initiated Morgan Stanley Overweight
View All

Kodiak Sciences Inc Stock (KOD) Latest News

pulisher
Nov 20, 2024

Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

GSA Capital Partners LLP Makes New Investment in Kodiak Sciences Inc. (NASDAQ:KOD) - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Kodiak: Tarcocimab Faces High Barriers To Entry Despite Resurrection (Rating Upgrade) - Seeking Alpha

Nov 15, 2024
pulisher
Nov 15, 2024

Kodiak Sciences (NASDAQ:KOD) Given New $4.00 Price Target at Barclays - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Kodiak Sciences Inc (KOD) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Kodiak Sciences: Drug Shows 3x Longer Half-Life, Reports $43.9M Q3 Loss | KOD Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 11, 2024

Diabetic Retinopathy Clinical Trials 2024: FDA Approvals, - openPR

Nov 11, 2024
pulisher
Nov 11, 2024

Kodiak Sciences to Present at Two Major Healthcare Investor Conferences | KOD Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Report Finds Big Disparities in Americans' Well-Being by Region - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Hourglass-Shaped Stent Might Ease Tough-to-Treat Angina - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Bystanders More Readily Perform CPR If 911 Operator Instructs - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

How ADHD May Influence a Child's Weight - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Have an Implanted Defibrillator? Triple-Digit Heatwaves Could Pose Danger - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 11, 2024

Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two Decades - 69News WFMZ-TV

Nov 11, 2024
pulisher
Nov 07, 2024

Empowering Growth: Diabetic Macular Edema Market 2024 - openPR

Nov 07, 2024
pulisher
Nov 06, 2024

Age-Related Macular Degeneration Market Size in the 7MM is expected to Grow by 2034, estimates DelveInsight - Barchart

Nov 06, 2024
pulisher
Nov 01, 2024

Bow-legged girl 14 cm taller after life-changing surgery - 69News WFMZ-TV

Nov 01, 2024
pulisher
Nov 01, 2024

Kodiak Sciences (KOD) Price Target Increased by 25.00% to 5.10 - MSN

Nov 01, 2024
pulisher
Oct 25, 2024

Zacks Research Raises Earnings Estimates for Kodiak Sciences - MarketBeat

Oct 25, 2024
pulisher
Oct 22, 2024

Age-related Macular Degeneration Market Size is Set for Rapid - openPR

Oct 22, 2024
pulisher
Oct 22, 2024

Sanctuary Advisors LLC Purchases New Holdings in Denny’s Co. (NASDAQ:DENN) - Defense World

Oct 22, 2024
pulisher
Oct 21, 2024

3 US Penny Stocks With Market Caps Under $500M To Consider - Simply Wall St

Oct 21, 2024
pulisher
Oct 19, 2024

Financial Comparison: Kodiak Sciences (NASDAQ:KOD) & Fennec Pharmaceuticals (NASDAQ:FENC) - Defense World

Oct 19, 2024
pulisher
Oct 16, 2024

Wet Age-Related Macular Degeneration Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 16, 2024
pulisher
Oct 16, 2024

Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Pacific Seafood to take over Trident Seafoods’ Kodiak operations - just-food.com

Oct 15, 2024
pulisher
Oct 14, 2024

Campaigning begins for Japan's parliamentary election - 69News WFMZ-TV

Oct 14, 2024
pulisher
Oct 14, 2024

KODKodiak Sciences Inc Latest Stock News & Market Updates - StockTitan

Oct 14, 2024
pulisher
Oct 14, 2024

Kodiak Sciences to Present at Innovate Retina 2024 - cnhinews.com

Oct 14, 2024
pulisher
Oct 14, 2024

Retinal Vein Occlusion Market Size is Set for Rapid Growth as - openPR

Oct 14, 2024
pulisher
Oct 14, 2024

How early is too early to prep for Thanksgiving? - 69News WFMZ-TV

Oct 14, 2024
pulisher
Oct 14, 2024

Expect employers to get more picky about who you see for care - 69News WFMZ-TV

Oct 14, 2024
pulisher
Oct 12, 2024

Documents show OpenAI's long journey from nonprofit to $157B valued company - 69News WFMZ-TV

Oct 12, 2024
pulisher
Oct 11, 2024

Could Certain Genes Help You Slim Down? - 69News WFMZ-TV

Oct 11, 2024
pulisher
Oct 10, 2024

Kodiak Counts on Tarcocimab Eye Disease Program Despite Setbacks - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

Having COVID-19 doubles risk of heart attack or stroke: study - 69News WFMZ-TV

Oct 09, 2024
pulisher
Oct 08, 2024

VEGFR-2 Antagonists Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight - GlobeNewswire

Oct 08, 2024
pulisher
Oct 06, 2024

Innovator U.S. Equity Accelerated 9 Buffer ETF – January (BATS:XBJA) Shares Sold by Cetera Investment Advisers - Defense World

Oct 06, 2024
pulisher
Oct 01, 2024

Vanguard Personalized Indexing Management LLC Buys Shares of 17,896 Redfin Co. (NASDAQ:RDFN) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Stock Price Up 4.8% - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Susquehanna Portfolio Strategies LLC Has $330,000 Stake in SandRidge Energy, Inc. (NYSE:SD) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Xponance Inc. Sells 12,667 Shares of Mattel, Inc. (NASDAQ:MAT) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Inozyme Pharma (NASDAQ:INZY) Earns Outperform Rating from Wedbush - Defense World

Sep 30, 2024
pulisher
Sep 28, 2024

Retinal Disorder Treatment Market Share Report, Industry Share and Trends Analysis By 2033 - WhaTech

Sep 28, 2024
pulisher
Sep 27, 2024

Data Storage (NASDAQ:DTST) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 27, 2024

Evergreen Capital Management LLC Raises Position in Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NYSE:HASI) - Defense World

Sep 27, 2024
pulisher
Sep 26, 2024

Retinal Biologics Market Advancements Highlighted by Size, Share Analysis And Forecast Report 2024 To 2033 - WhaTech

Sep 26, 2024
pulisher
Sep 24, 2024

Goldman Sachs maintains sell rating on Kodiak Sciences stock By Investing.com - Investing.com South Africa

Sep 24, 2024

Kodiak Sciences Inc Stock (KOD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Kodiak Sciences Inc Stock (KOD) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
BORGESON JOHN A.
See Remarks
Jun 12 '24
Sale
2.92
1,558
4,549
179,544
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):